The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CYCN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | CYCN | PGEN | SCNX | CLIR |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 33 | 15 | 20 | 65 (highest) |
| Pricing power | — | 99 (highest) | 69 | 21 |
| Returns on capital | 0 | 0 | 4 (highest) | 0 |
| Balance-sheet safety | 55 (highest) | 28 | 28 | 55 (highest) |
| Capital discipline | 44 (highest) | 24 | 44 (highest) | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $14M | $1.8B | $16.1M | $17.3M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |